NEURODERM

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark NEURODERM was filed as Word mark on 05/04/2020 at the World Intellectual Property Organization.

Trademark Details Last update: September 27, 2022

Trademark form Word mark
File reference 1564385
Countries Australia Brazil Canada Switzerland Colombia European Community United Kingdom India Japan South Korea Mexico Norway Russia Turkey United States of America (USA)
Base trademark IL No. 326510, April 1, 2020
Application date May 4, 2020
Expiration date May 4, 2030

Trademark owner

3 Pekeris Street
7670212 Rehovot
IL

Trademark representatives

20 HaHarash St. Tel Aviv IL

goods and services

05 Pharmaceuticals, namely, pharmaceutical preparations for use in preventing or treating conditions, diseases, or disorders of the central nervous, neurological, cardiovascular, endocrine, gastric or gastroenteric, hematologic, immunologic, inflammatory, osteologic, or respiratory systems; pharmaceutical preparations for use in prevention or treatment of allergies or allergic responses, metabolic disorders, psychiatric or emotional disorders, infection or infectious diseases, pain; dermatologic pharmaceuticals for treatment of comorbidities and side effect conditions caused by a treatment of such conditions and/or stemming from the reference diseases; delivery kits comprising dressings for medical, surgical, and veterinary use; drug delivery agents, namely, patches sold with medication
10 Medical devices for delivery of medicated and pharmaceutical preparations; drug delivery device; infusion sets; electromagnetic drug delivery apparatus for medical use; medical apparatus, namely, implantable ports; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and medical instruments for administering fluid, drugs, arid nutrition, namely, infusion pumps, patch pumps, wearable injectors, and handheld injectors; medical syringes; medical devices in the nature of infusion pumps for drugs infusion and for monitoring the infusion of drugs for use with integrated software for transmission and/or receiving of drug infusion data, data related to the infusion pumps, drug infusion monitoring, filling or emptying of drug vials, and patient's behavior and/or reaction to drugs, sold as a unit therewith; drug delivery device for carrying pharmaceuticals or drugs for medical treatment; drug delivery devices and accessories thereof, namely, catheters, pen needles, injection needles, syringes and implantable subcutaneous drug delivery devices; infusion sets; lancets; lancing devices for delivering medication; drug eluting stents; bio-absorbable stents; stent grafts; medical diagnostic apparatus used to detect and measure the level of substances in body fluids; apparatus for measuring dosages and delivering pharmaceuticals, namely, medical pumps and pens; electromedical rehabilitative and pain management products for clinical and home use, namely, electrical nerve and muscle stimulators, ultrasonic stimulators, magnet therapy stimulators and laser therapy stimulators; electronic-kinetic transdermal drug delivery control unit for the treatment of diseases

Trademark history

Date Document number Area Entry
September 23, 2022 2022/39 Gaz NO RAW: Rule 18ter(2)(ii) GP following a provisional refusal
September 1, 2022 2022/36 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
May 31, 2022 2022/23 Gaz MX Rejection
April 4, 2022 2022/14 Gaz CA Rejection
March 10, 2022 2022/11 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
January 20, 2022 2022/4 Gaz EM RAW: Rule 18ter(2)(i) GP following a provisional refusal
December 14, 2021 2021/50 Gaz BR Rejection
November 17, 2021 2021/46 Gaz KR Rejection
November 17, 2021 2021/46 Gaz CH RAW: Rule 18ter(2)(i) GP following a provisional refusal
November 11, 2021 2021/45 Gaz JP Rejection
October 25, 2021 2021/43 Gaz RU RAW: Rule 18ter(2)(ii) GP following a provisional refusal
October 11, 2021 2021/41 Gaz TR Rejection
October 6, 2021 2021/42 Gaz EM RAW: No Effect Limitation
September 14, 2021 2021/37 Gaz CO Rejection
September 11, 2021 2021/37 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
July 15, 2021 2021/31 Gaz RAW: Limitation
July 3, 2021 2021/28 Gaz NO Rejection
July 1, 2021 2021/26 Gaz GB Rejection
June 28, 2021 2021/30 Gaz IN RAW: Rule 18ter(2)(ii) GP following a provisional refusal
May 6, 2021 2021/19 Gaz EM Rejection
April 12, 2021 2021/16 Gaz CH Rejection
March 23, 2021 2021/12 Gaz AU Rejection
March 22, 2021 2021/14 Gaz IL RAW: Partial Ceasing Effect
March 22, 2021 2021/12 Gaz RU Rejection
January 28, 2021 2021/6 Gaz RAW: Limitation
December 30, 2020 2021/1 Gaz US Rejection
December 28, 2020 2021/1 Gaz IN Rejection
May 4, 2020 2020/48 Gaz IL Registration

ID: 141564385